HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website Save this grant

Next deadline: May 19, 2024 (Letter of inquiry)

Later deadlines: Jun 18, 2024 (Full proposal), Aug 18, 2024 (Letter of inquiry), Sep 17, 2024 (Full proposal), Dec 29, 2024 (Letter of inquiry), Jan 28, 2025 (Full proposal), Apr 16, 2025 (Letter of inquiry), May 16, 2025 (Full proposal), Aug 18, 2025 (Letter of inquiry), Sep 17, 2025 (Full proposal), Dec 17, 2025 (Letter of inquiry), Jan 16, 2026 (Full proposal), Apr 15, 2026 (Letter of inquiry), May 15, 2026 (Full proposal), Aug 18, 2026 (Letter of inquiry), Sep 17, 2026 (Full proposal), Dec 16, 2026 (Letter of inquiry), Jan 15, 2027 (Full proposal)

Grant amount: Up to US $350,000

Fields of work: Pharmacology Anesthesia and Pain Medicine

Applicant type: Organizations

Funding uses: Research

Location of project: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico Show all

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico Show all

Overview:

NOTE:

  • Letter of Inquiry (Letter of Intent) - This is due 30 days prior to the application due date (due by 5:00 pm local time of applicant organization).
  • NOTE: The following deadlines apply to standard grant applications (due by 5:00 pm local time of applicant organization):
    • June 18, 2024
    • September 17, 2024
    • January 28, 2025
    • May 16, 2025
    • September 17, 2025
    • January 16, 2026
    • May 15, 2026
    • September 17, 2026
    • January 15, 2027
  • The following deadlines apply to Renewal/Resubmission/Revision grant applications (due by 5:00 pm local time of applicant organization):
    • June 18, 2024
    • September 17, 2024
    • January 28, 2025
    • May 16, 2025
    • September 17, 2025
    • January 16, 2026
    • May 15, 2026
    • September 17, 2026
    • January 15, 2027

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Purpose

This notice of funding opportunity (NOFO) aims to encourage research grant applications for initial translational efforts that will enable a drug discovery program for novel, non-opioid, and non-addictive treatments for pain. The program provides funding to develop and validate assays to support a distinct testing funnel and conduct screening efforts to identify and characterize potential therapeutic agents including small molecules, biologics, and natural products. Preliminary in vivo pharmacokinetic, pharmacodynamic, and efficacy studies may also be supported. The goal of this NOFO is to advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program or other later-stage translational programs.

This NOFO is part of the NIH Helping to End Addiction Long Term (HEAL) initiative to accelerate the discovery and preclinical development of safe and effective therapeutics to treat pain with little or no addiction liability.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

US Dept. of Health & Human Services: National Institutes of Health (NIH)
FUNDER

Your history with this funder
0
SAVED OPPORTUNITIES
No saved opportunities from this funder yet
FUNDER NOTES
Save this opportunity to add notes...
CONTACTS
Save this opportunity to add contacts...

Other Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

Forecasted Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih) help icon

Don't miss out on other good fit funders!

Get personalized grant recommendations, tracking and more by creating a free 14-day account.

No credit card required.
instrumentl testimonial face

"Winning 30% more grants thanks to Instrumentl was a huge morale boost. My confidence continues to grow."

Linda Rucker, Grant Writer

This page was last reviewed March 29, 2024 and last updated March 29, 2024